1,4-Disubstituted-[1,2,3]triazolyl-Containing Analogues of MT-II: Design, Synthesis, Conformational Analysis, and Biological Activity
D’Ursi, Anna M.
Dirain, Marvin L.
Papini, Anna M.Note: Order does not necessarily reflect citation order of authors.
MetadataShow full item record
CitationTesta, C., M. Scrima, M. Grimaldi, A. M. D’Ursi, M. L. Dirain, N. Lubin-Germain, A. Singh, et al. 2014. “1,4-Disubstituted-[1,2,3]triazolyl-Containing Analogues of MT-II: Design, Synthesis, Conformational Analysis, and Biological Activity.” Journal of Medicinal Chemistry 57 (22): 9424-9434. doi:10.1021/jm501027w. http://dx.doi.org/10.1021/jm501027w.
AbstractSide chain-to-side chain cyclizations represent a strategy to select a family of bioactive conformations by reducing the entropy and enhancing the stabilization of functional ligand-induced receptor conformations. This structural manipulation contributes to increased target specificity, enhanced biological potency, improved pharmacokinetic properties, increased functional potency, and lowered metabolic susceptibility. The CuI-catalyzed azide–alkyne 1,3-dipolar Huisgen’s cycloaddition, the prototypic click reaction, presents a promising opportunity to develop a new paradigm for an orthogonal bioorganic and intramolecular side chain-to-side chain cyclization. In fact, the proteolytic stable 1,4- or 4,1-disubstituted [1,2,3]triazolyl moiety is isosteric with the peptide bond and can function as a surrogate of the classical side chain-to-side chain lactam forming bridge. Herein we report the design, synthesis, conformational analysis, and functional biological activity of a series of i-to-i+5 1,4- and 4,1-disubstituted [1,2,3]triazole-bridged cyclopeptides derived from MT-II, the homodetic Asp5 to Lys10 side chain-to-side chain bridged heptapeptide, an extensively studied agonist of melanocortin receptors.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:23474014
- HMS Scholarly Articles